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ABSTRACT 
Background and Objective: The rheumatoid arthritis is autoimmune disease and it is a major health issues among the peoples in worldwide. 
People affected by rheumatism have double risk of heart disease, lungs and chest infections, which causes 10-20% of deaths in individuals. The 
present research work was aimed to evaluate the antiarthritic potential of synthesized silver nanoparticles from the aqueous extract of 
M.concanensis leaves. 
Material and Methods: The arthritis was induced by complete freund’s adjuvant method and the rats was treated with synthesized silver 
nanoparticles from aqueous extract of M.concanensis leaves. The body weight, paw volume, hematological parameters, liver function marker 
enzymes and the renal function markers of the arthritic rats and nanoparticles treated rats was analyzed by the standard methods.  
Results: The results of the present study were made the new findings in antiarthritic activity of silver nanoparticles from M.concanensis leaves. 
The nanoparticles showed a noteworthy antiarthritic activity against FCA induced rheumatoid arthritis in experimental rats.  
Conclusion: Based on the above results, it was concluded as the present work are states the better understand on the antiarthritic activity of 
silver nanoparticles of Moringa concanensis Nimmo leaves. 
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1. INTRODUCTION 
Rheumatoid arthritis is an autoimmune disease with joint 
inflammation, synovial proliferation and destruction of 
articular cartilage and the majority is seen in female. 
Prolonged treatment with allopathic drugs causes adverse 
side effect and hence alternative natural measure is in 
search1. In the year of 2007, arthritis foundation has 
projected that two third of the population was suffering 
from arthritis and census reports that by 2030, this was 
increases beyond to 40%2. People affected by rheumatism 
have double risk of heart disease, lungs and chest infections, 
which causes 10-20% of deaths in individuals. Inflammation 
was the important pathological change of rheumatoid 
arthritis3.The inefficiency of renal function is directly 
associated with the development of joint pain. The 
management of rheumatoid arthritis is a multidisciplinary 
approach in order to reduce the pain, decreases of 
inflammation and restoration of joints function. However, 
progresses in understanding the pathogenesis of the disease 
have encouraged the development of new approachable 
therapeutics, with enhanced outcomes4. In practical terms 
suppression of inflammation is the target intensive therapy. 
Herbal medicines have become popular for the treatment of 
rheumatoid arthritis in worldwide recently5-7. 
The applications of silver nanoparticles on different areas 
like medicines, chemistry, catalysis and electronics are well 
known8. The production of silver nanoparticles can be done 
by physical methods, chemical methods and biological 
methods. Among these methods, the biological methods of 
silver nanoparticles synthesis are eco-friendly; no toxic or 
harmful chemicals were utilized for the production of silver 
nanoparticles9,10. In this method, the plant extracts, enzymes, 
proteins, antioxidants, triglycerides, saponins, glycoproteins, 
polysaccharides, terpenes, flavonoids, and tannins are used 
for the reduction and stabilization of nanoparticles11. The 
present study deals with the evaluation the antiarthritic 
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activity of synthesized silver nanoparticles from 
M.concanensis leaves in experimental rats. 
2. MATERIAL AND METHODS 
2.1 Collection and identification of plant 
The healthy, matured and insect bites free leaves of Moringa 
concanensis Nimmo plant (Family - Moringaceae) was 
collected from Esanai village, Perambalur district, 
Tamilnadu, India (Latitude – 11.2982° N, Longitude – 
78.8298° E). The plant sample was identified and 
authenticated by Dr. C. Murugan, Scientist, Botanical Survey 
of India, Southern Regional Centre, Coimbatore, Tamilnadu, 
India. The identification number BSI/SRC/5/23/2016/Tech-
152. 
2.2 Synthesis of silver nanoparticles 
2.2.1 Preparation of plant extract  
The 10 gms of the dried M.concanensis Nimmo leaves 
powder were kept in a beaker containing 100 ml double 
distilled water and boiled at 80˚C for 10 minutes to obtained 
bioactive compounds from Moringa concanensis Nimmo 
leaves. The extract was cooled and filtered through normal 
filter paper followed by Whatmann filter paper No.1. The 
final extract was used to synthesis silver nanoparticles.  
2.2.2 Synthesis of silver nanoparticles  
The aqueous solution of silver nitrate (AgNO3) at 
concentration of 0.001 M was prepared to synthesize silver 
nanoparticles. The 5 ml Moringa concanensis Nimmo leaves 
aqueous extract was slowly added to 95 ml of aqueous 
solution of AgNO3 while stirring. The formation reddish 
brown colour was observed after 3 hrs incubation at room 
temperature. Then the AgNPs solution was purified by 
repeated centrifugation at 10,000 rpm for 20 minutes. After 
centrifugation the obtained particles were washed with 
distilled water for 10 to 20 minutes and kept in hot air oven 
for drying at 100˚C for 1 hour. 
2.2.3 Characterization of silver nanoparticles  
2.2.3.1 UV-Visible spectroscopy analysis 
The formation and stability of silver nanoparticles in 
aqueous solution was confirmed by UV-Visible 
spectrophotometer analysis. The reduction of pure Ag+ ions 
was monitored by measuring the UV-Visible spectrum of the 
reaction medium at 540 nm for 12 hours. UV-Visible spectral 
analysis was done by UV-Visible spectrophotometer (UV- 
2450, Shimadzu).  
2.2.3.2 Fourier transform – Infra red analysis (FT-IR) 
The FT-IR spectroscopy measurements are carried out to 
identify the biomolecules that bound specifically on the 
silver surface and local molecular environment of capping 
agent on the nanoparticles. To remove any free biomass 
residue or compound that is not the capping ligand of the 
nanoparticles, the residual solution of 100 ml after reaction 
was centrifuged at 10,000 rpm for 10 mins and the resulting 
suspension was redispersed in 10 ml sterile distilled water. 
Thereafter, the purified suspension was freeze dried to 
obtain dried powder. Finally, the dried nanoparticles were 
analysed by FT-IR spectrophotometer. 
2.3 Selection of animals 
Healthy adult male wistar albino rats weighing about 150 to 
200g were obtained from Viprogen Bioscience Private 
Limited, Mysore. They were housed in polypropylene cages 
under the standard laboratory condition (25 ± 2˚C, humidity 
60-70%, 12 hours light / dark cycles). The rats were fed with 
commercial rat pellet diet and water was provided ad 
libitum. The rats were acclimatized to laboratory conditions 
for one week prior to the commencement of the 
experiments. The animal care and handling were done 
according to the regulations of council directive of 
committee for the purpose of control and supervision of 
experiments on animals (CPCSEA) on animal 
experimentations. The clearance No: VIP/IAEC/8/2016). All 
animal experiments were performed in the laboratory 
according to the ethical guidelines suggested by the 
International Animal Ethics Committee (IAEC). 
2.4 Preliminary animal studies in toxicity studies of 
dose fixing for silver nanoparticles  
2.4.1 Experimental design 
Group I       : Normal rats (Standard diet)Gr 
oup II      : Rats fed orally with silver nanoparticles of 
Moringa concanensis Nimmo  50 µg/kg body weight for 14 
days. 
Group III     : Rats fed orally with silver nanoparticles of 
Moringa concanensis Nimmo 100 µg/kg body weight for 14 
days. 
Group IV     : Rats fed orally with silver nanoparticles of 
Moringa concanensis Nimmo 150 µg/kg body weight for 14 
days. 
Group V      : Rats fed orally with silver nanoparticles of 
Moringa concanensis Nimmo  200 µg/kg body weight for 14 
days. 
They were continuously observed for 4 hrs to detect any 
changes in the behavior in relation to the posture, mood and 
motor activity. 
2.4.2 Induction of arthritis 
Arthritis was induced by 0.1 ml injection of freund’s 
complete adjuvant emulsion (FCA) into the sub-planter 
surface of right hind paw12. 
2.4.3 Experimental design for evaluation of antiarthritic 
activity 
After one week of acclimatization period, the rats were 
divided into four groups with six rats in each. 
Group I : Control rats fed with standard diet and water ad 
libitum. 
Group II : Arthritis induced rats received 0.01 ml of FCA 
intradermally. 
Group III    : Arthritis induced rats received silver 
nanoparticles of M.concanensis Nimmo leaves (150 µg / kg 
body weight) by i.p administration for 28 days.Group I 
V     : Arthritis induced rats received Diclofenac (standard 
drug) 10 mg / kg body weight by oral administration for 28 
days. 
2.5 Collection of samplesAfter the experimental regimen (4 
weeks), the rats were sacrificed by cervical dislocation 
under mild chloroform anesthesia. Blood was collected in 
EDTA coated centrifuge tubes by an incision made in the 
jugular veins and serum was separated by centrifugation at 
2000 rpm for 20 minutes and utilized for various 
biochemical assays. The liver and hind limb were excised 
immediately and thoroughly washed with ice cold 
physiological saline and blotted dry. A part of the tissues 
such as liver and hind limb were removed and fixed in 10% 
formalin for histopathological studies.  
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2.5.1 Body weight  
The initial and final body weight of each rat was assessed 
using a sensitive balance and recorded. 
2.5.2 Measurement of paw volume 
The mean increase in the paw volume of each group was 
measured the initial and final days using digital 
plathysmograph (Ugobasile, Italy). 
2.5.3 Hematological parameters 
The haematological parameters such as haemoglobin, PCV, 
WBC, RBC and Platelets were assayed. The whole blood 
sample was analysed for the changes in the blood cells using 
SYSMEX Xs – 800 i automatic haematology analyzer. 
2.5.4 Estimation of erythrocyte sedimentation rate 
(ESR)  
To determine the rate at which the red blood cells sediment 
by the Westergren’s Method. Collect 1.6 ml blood in a plain 
acid washed glass tube containing 0.4 ml of 3.8% sodium 
citrate till the minimum fill level indicated on the label. If 
K2EDTA blood is used, add 0.5 ml of 3.8% sodium citrate to 2 
ml of K2EDTA blood. Mix the blood with sodium citrate 
solution immediately by gently inverting the tube at least 6 
times. Place the Westergren’s tube up right and exactly 
vertical in the stand, note the time, allow standing exactly for 
1 hour, and note the level to which the red blood cell has 
settle down at the end of 1 hour. 
2.5.5 Assay of hematological parameters 
After induction of rheumatoid arthritis blood sample were 
collected from infected wistar albino rats. The hematological 
parameters like Hb, PCV, WBC, RBC, Platelates and ESR were 
assayed. The blood samples were analysed for the changes 
in the blood cells using hematology analyser. 
2.6 Estimation of liver marker enzymes 
2.6.1 Estimation of aspartate transaminase 
In different test tubes, 1 ml of buffered substrate was added 
to 0.1 ml of serum or 0.1 ml of liver homogenate and 
incubated at 37˚C for 1 hr. Then 1 ml of DNPH reagent was 
added to arrest the reaction. Then the blank tubes 0.1 ml of 
distilled water was added instead of serum. The tubes were 
kept inside for 15 minutes, and then 10 ml of 0.4 N sodium 
hydroxide was added and read at 520 nm in UV 
spectrophotometer. The enzyme activity was expressed as 
IU/litre for serum and micromole of pyruvate 
liberated/hour/mg protein for liver homogenate. 
2.6.2 Estimation of alanine transaminase 
0.2 ml of sample, added 1 ml of the buffered substrate and 
incubated for 30 minutes at 37oC. The control tubes, enzyme 
was added after arresting the reaction with 1 ml of DNPH 
and the tubes was kept at room temperature for 20 minutes. 
Then 10 ml of 0.4N NaOH was added. A set of standard 
pyruvate in the concentration 0.4 to 2 µm was also treated in 
a similar manner. The colour developed was read at 520 nm. 
The enzyme activity was expressed as µmoles of pyruvate 
liberated per litre in serum.  
2.6.3 Estimation of alkaline phosphatase  
Pipetted out 4.0 ml of the buffered substrate into a test tube 
and incubated at 37˚C for 5 minutes. 0.2 ml of serum was 
added and incubated for 15 minutes. Removed and 
immediately added 1.8 ml of diluted phenol reagent. A 
control was run simultaneously with 4 ml buffered substrate 
and 0.2 ml sample to which 1.8 ml phenol reagent was added 
immediately. Mixed well and centrifuged. 4 ml of the 
supernatant added 2 ml of sodium carbonate. Standards 
were also run. Incubated all the tubes at 37˚C for 15 minutes, 
the colour developed were measured at 700 nm. The enzyme 
activity was expressed as µmoles of phenol per litre in 
serum.  
2.6.4 Estimation of acid phosphatase  
Pipetted out 4 ml of the buffered substrate into a test tube 
and incubated at 37˚C for          5 minutes. Then add 0.2 ml of 
sample and incubated for 60 minutes and removed then 
immediately added 1.8 ml of diluted phenol reagent. At the 
same time a control was set up containing 4 ml buffered 
substrate and 0.2 ml of sample to which 1.8 ml of phenol 
reagent was added immediately. Mixed well and centrifuged. 
4 ml of the supernatant added 2 ml of sodium carbonate. 
Take 4 ml of working standard solution and for blank taken 
3.2 ml water and 0.8 ml of phenol reagent. Then add 2 ml of 
sodium carbonate. All the tubes were incubated at 37˚C for 
15 minutes. Read the colour development at 700 nm. The 
activity of serum acid phosphatase was expressed in μmoles 
of phenol liberated per litre. The activity in tissue 
homogenate was expressed as μmoles of phenol 
liberated/min/mg protein. 
2.6.5 Estimation of lactate dehydrogenase 
Place 1 ml buffered substrate and 0.1 ml sample into each of 
two tubes. Add 0.2 ml of water to the blank. Then to the test 
add 0.2 ml of NAD. Mixed and incubated at 37˚C for 15 
minutes. Exactly after 15 minutes, 1 ml of dinitrophenyl 
hydrazine was added to each (test and control). Tube 
acclimatized for 15 minutes, and then added 10 ml of 0.4N 
sodium hydroxide and the colour developed was read 
immediately at 440 nm. A standard with sodium pyruvate 
solution with the concentration range 0.1 - 1 μmole was 
taken. LDH activity in serum was expressed as micromoles 
of pyruvate liberated per litre.  
2.6.6 Estimation of γ-glutamyl transferase (γ-GT)  
0.5 ml of serum was added to the incubation mixture 
containing 0.5 ml gamma-glutamyl p-nitroanilidine, 2 ml 
glycyl glycine and 1 ml buffer. After incubation for 30 
minutes at 37˚C the reaction was arrested by the addition of 
1 ml of 10% acetic acid. 
The amount of p-nitroaniline liberated in the supernatant 
was measured as the difference in optical density at 410 nm, 
between samples with and without substrate. The substrate 
incubated in the absence of serum under the same condition 
was used as a reference blank. Enzyme activity was 
expressed as IU/l for serum. 
2.6.7 Estimation of glucose  
The 0.1 ml of blood was mixed with 1.9 ml of Tricorboxylic 
acid solution to precipitate protein and then centrifuged. 1 
ml of the supernatant was mixed with 4 ml of O-toluidine 
reagent and was kept in a boiling water bath for 15 minutes 
and the green colour developed was read at 600 nm, in UV 
spectrophotometer. A set of standard glucose solution were 
also treated similarly. The value was expressed as mg/dl 
blood.  
2.6.8 Estimation of total cholesterol  
10 ml of ferric chloride – uranyl acetate reagent was added 
to 0.1 ml of sample (serum), mixed well and allowed to stand 
for 5 minutes and centrifuged. 3 ml of the supernatant was 
taken for the analysis. Similarly 0.1 ml of standard 
cholesterol was mixed and 3 ml of aliquot was taken. Blank 
tubes contained 3 ml of ferric chloride – uranyl acetate 
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reagent 2 ml of ferrous sulphate – sulfuric acid reagent was 
added to all the tubes and mixed well. The colour intensity 
was measured at 540 nm after 20 minutes in a UV visible 
spectrophotometer. The serum cholesterol was expressed as 
mg/dl. 
2.6.9 Estimation of triglycerides  
The 4 ml of isopropanol was added to 0.1 ml of sample 
(serum) and mixed well, followed by 0.4 g of alumina and 
shaken well for 15 minutes. Centrifuged at 2000 rpm for 10 
minutes and then 2 ml of the supernatant fluid was 
transferred to appropriately labeled tubes. The tubes were 
placed in a water bath at 65˚C for 15 minutes for 
saponification after adding 0.6 ml of the saponification 
reagent. After adding 1ml of sodium meta periodate was 
added followed by 0.5ml of acetyl acetone reagent. After 
mixing the tubes were kept in a water bath 65˚C for half an 
hour. The contents were cooled and the absorbance was 
measured at 430 nm against a blank in a UV-visible 
spectrophotometer. Triglyceride content of the serum was 
expressed as mg/dl. 
2.7 Estimation of renal function markers 
2.7.1 Estimation of urea  
The 0.1ml of blood was added to 3.3ml of water and mixed 
with 0.3 ml of 10% sodium tungstate and 0.3 ml of 0.67 N 
sulfuric acid reagents. The suspension was centrifuged and 
to 1ml of the supernatant 1ml of water, 0.4ml of diacetyl 
monoxime and 2.6 ml of sulfuric acid – phosphoric acid 
reagents were added in that order and kept in a boiling 
water bath for 30 minutes. This was cooled and the colour 
developed was measured at 480 nm in a UV-visible 
spectrophotometer. Aliquots of urea were also treated in a 
similar manner. The value was expressed as mg/dl blood.  
2.7.2 Estimation of creatinine  
A protein free filtrate was prepared by precipitating a serum 
with 8 ml of water, 0.5 ml of 3N sulfuric acid and 0.5 ml of 
10% sodium tungstate. After centrifugation, 5 ml of the clear 
filtrate was taken. Then this was added 1.5 ml saturated 
picric acid solution and 1.5 ml of 0.75 N sodium hydroxide. 
The colour intensity was measured at 470 nm after 15 
minutes. Standard and blank were also processed similarly. 
Serum creatinine levels were expressed as mg/dl. 
2.7.3 Estimation of uric acid  
0.1 ml of the sample, 2.9 ml of water was added, followed by 
0.6 ml each of phosphotungstic acid and sodium carbonate. 
A blank was set up with 3 ml water. Standards were also 
treated in the same manner. The colour was read at 640 nm 
after 10 minutes. The result was expressed as mg / dl in 
serum.  
2.7.4 Estimation of protein  
Pipetted out 1.0 ml of working standard solution, 0.1 ml of 
the sample was taken.         The volumes in all the tubes were 
made upto 1 ml with distilled water. Add 5 ml of alkaline 
copper reagent to each tube. Mixed well and allowed to 
stand for 10 minutes. Then add 0.5 ml of Folin-Ciocalteau 
reagent. Mixed well and incubated at room temperature for 
30 minutes. A reagent blank was also prepared. After 30 
minutes, the blue colour developed was measured at 660 
nm.  
2.7.5 Estimation of albumin 
Take three test tubes labeled B (blank), S (standard) and T 
(test). The blank solution contains 1000 µl of reagent and 10 
µl of distilled water. The standard solution contains 1000 µl 
of reagent with 10 µl of standard solution. The test solution 
contains 1000 µl of reagent with 10 µl of sample solution. Set 
the instrument to zero with reagent blank. Mixed thoroughly 
incubated test tube at room temperature for 3 minutes. Read 
absorbance at 630 nm or red filter (620–650 nm). The 
values were expressed in g / dl in serum.  
2.7.6 Estimation of C – Reactive protein (CRP) 
Pipetted out the 990 μl of wash buffer into a test tube. Add 
10 μl of the provided standard (1:100 dilution) to create the 
top standard, 10 ng / ml. Dilute samples as necessary in 
wash buffer. Serum sample should be diluted at least 1:4,000 
prior to assay. Add 100 μl of standard or sample per well of 
the microwell plate. Record locations of each addition for 
later reference. Seal plate with an adhesive strip and 
incubate at room temperature for 2 hrs. Dilute the HRP-
conjugated antibody 1:100 in wash buffer. 9.9 ml of wash 
buffer, add 100 μl of stock conjugate. Add 100 μl of the 
diluted conjugate to each well of the plate. Seal and incubate 
for 1 hour at room temperature. Each well, add 100 μl of the 
TMB substrate solution. A blue colour indicates a positive 
reaction. Allow reaction to proceed at room temperature for 
5-10 minutes. The reaction was stopped by adding 100 μl of 
stop solution per well. The reaction mixture should turn to 
yellow. Read the absorbance (OD) on an ELISA plate reader 
equipped with a 450 nm filter. If wavelength correction is 
available, set to 570 nm. Readings made without wavelength 
correction may be higher and less accurate. Use the standard 
curve to determine the amount of CRP present in the 
samples. The concentration read from the curve should be 
multiplied by the dilution factor for any diluted samples. 
2.8 Histopathological investigation of hind limb and 
liver  
The hind limb and liver was removed, washed with ice cold 
saline and a small portion of this was quickly fixed in 10% 
formalin.  
2.8.1 Tissue processing 
The tissues were placed in 10% formal saline (10% formalin 
in 90% sodium chloride) for one hour to rectify shrinkage 
due to higher concentration of formalin. The tissue was 
dehydrated by ascending grades of isopropyl alcohol by 
immersing in 80% isopropanol overnight, 100% isopropyl 
alcohol for 1 hour. The dehydrated tissues were cleared in 
two changes of xylene, 1 hour each. Then the tissues were 
impregnated with histology grade paraffin wax (melting 
point 58 - 600˚C) at 600˚C for 2 changes of 1 hour each. The 
wax impregnated tissues were embedded in paraffin blocks, 
mounted and cut with rotary microtome at 3 micron 
thickness. The sections were floated on tissue floatation bath 
at 400˚C and taken on glass slides and smeared with equal 
parts of egg albumin and glycerol. The sections were then 
melted in an incubator at 600˚C and after    5 minutes and 
the section were allowed to cool. 
2.8.2 Tissue staining 
The sections were deparaffinised by immersing in xylene for 
10 minutes in horizontal staining jar. The deparaffinised 
section were washed with 100% isopropyl alcohol and 
stained in Ehrlish’s hematoxylin for 8 minutes in horizontal 
staining jar. After stained in hematoxylin, the sections were 
washed with tap water and dipped in acid alcohol to remove 
excess stain (8.3% HCl in 70% alcohol). The sections were 
then placed in running tap water for 10 minutes for blueing 
(show alkalization). The section were counter stained in 1% 
aqueous eosin (1 g in 100 ml tap water) for one minute and 
the excess stain was washed with tap water and the sections 
were allowed to dry. Complete dehydration of stained 
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sections was ensured by placing the section in the incubator 
at 600°C. When the sections were cooled, they were 
mounted in DPX mount having the optical index of glass (the 
section were wetted in xylene and inverted on to the 
mountant placed on cover slip). The architecture was 
observed at low power objective. The liver cell injury and 
other aspects were observed under high power dry 
objective. 
2.9 Statistical analysis 
The values were expressed as Mean ± SD. Significant 
difference have been observed using One Way Analysis of 
Variance (ANOVA) by SPSS software version 19.0. The 
p<0.05, was considered as significant difference. 
3. RESULT 
3.1 Biosynthesis of silver nanoparticles from Moringa 
concanensis Nimmo leaves 
3.1.1 Visual observation 
The silver nanoparticles were synthesized from aqueous 
extract of Moringa concanensis Nimmo leaves. The formation 
of silver nanoparticles from reaction medium was confirmed 
by colour change. The reaction mixture contains the aqueous 
extract of M.concanensis Nimmo leaves and aqueous silver 
nitrate solution. After the 24 hrs of dark incubation the 
colour of the reaction medium was changed from light 
brown to black. This result indicates the formation of silver 
nanoparticles by the reduction of Ag ions.  
3.1.2 UV-Visible Spectroscopy analysis of synthesized 
silver nanoparticles from aqueous extract of 
M.concanensis Nimmo leaves 
The UV spectrum showed the surface plasma AgNPs at 
increasing concentration was taken and the colour changes 
were observed for nanoparticles. For silver colour changes 
from colourless to dark brown colour. Metal nanoparticles 
can be synthesized by reducing metal ions using some 
chemical molecules. In green synthesis, this is observed that 
natural material extract act as reducing agent for generation 
of metal nanoparticles.  
3.1.3 Fourier transform – infrared red (FT-IR) analysis 
of synthesized silver nanoparticles from aqueous 
extract of M.concanensis Nimmo leaves 
The FT-IR spectroscopy measurements were carried out to 
identify the biomolecules that bound specifically on the 
silver surface and local molecular environment of capping 
agent on the nanoparticles. The synthesized silver 
nanoparticles were analyzed by FT-IR spectrophotometer. 
The FT-IR spectra of biosynthesized AgNPs from 
M.concanensis Nimmo leaves extract, showed in figure 15, 
indicates the presence of carboxylic, hydroxyl, alkanes, 
alkenes and carbonyl groups. Display of strong broad O–H 
stretch carboxylic bands in the region 3273.34 cm-1 and 
carbonyl stretching bands in the region 1070.54 cm-1 was 
observed. The peaks appearing in the region 1630.88 cm-1 
are attributed by the alkene group. The alkanes stretching 
bands was observed in the region of 2847.05 cm-1 and 
2915.53 cm1 in FT-IR spectrum.  
3.2 Effect of Silver nanoparticles of Moringa concanensis 
leaves on hematological parameters in blood of 
experimental rats 
For the dose fixation studies on the anti-rheumatoid arthritis 
efficiency of synthesized silver nanoparticles from aqueous 
leaves extract of Moringa concanensis Nimmo against 
freund’s complete adjuvant (FCA) intoxicant, we focused on 
the effect of silver nanoparticles from aqueous leaves extract 
of Moringa concanensis Nimmo on hematological parameters 
in the blood of experimental rats. The dose fixation study 
was employed in various concentration of silver 
nanoparticles i.e., 50 µg/ kg b. w to 200 µg/ kg of body 
weight. The table 1 showed that there was a no significant 
(p<0.05) changes in hemoglobin, packed cell volume (PCV), 
white blood cells (WBCs), red blood cells (RBCs) and 
platelets with EEMC up to 150 µg/ kg of body weight in 
relation with control group. However 200 µg/ kg b.w of 
silver nanoparticles treated rats showed a significant 
(p<0.05) decrease in relative blood components. The 
significant (p<0.05) decreases in these blood components 
may due to the higher doses of silver nanoparticles. Hence 
the 150 µg/ kg concentration was selected as optimum dose 
(table 1). 
  
Table 1: Effect of silver nanoparticles on hematological parameters 
Experimental groups 
Hb 
(g %) 
PCV  
(%) 
WBC 
(103 /µl) 
RBC 
(1012/ µl) 
Platelets 
(109 /µl) 
Group  I 
(Control) 
12.6 ± 0.30 37.50 ± 0.81 6.50 ± 0.40 5.80 ± 0.30 5.24 ± 0.30 
Group  II 
(50 µg / kg b.w) 
12.6 ± 0.20 37.50 ± 0.60 6.40 ± 0.50 5.75 ± 0.40 5.23 ± 0.50 
Group  III 
(100 µg / kg b.w) 
12.5 ± 0.30 37.50 ± 0.50 6.50 ± 0.40 5.80 ± 0.30 5.24 ± 0.30 
Group  IV 
(150 µg / kg b.w) 
12.6 ± 0.10 37.50 ± 0.40 6.50 ± 0.50 5.80 ± 0.31 5.25 ± 0.20 
Group  V 
(200 µg / kg b.w) 
12.1 ± 0.30 37.00 ± 0.30 6.10 ± 0.30 5.20 ± 0.40 4.90 ± 0.40 
Values are expressed as mean ± SD of six animals in each group (p < 0.05) 
 
3.3 Antiarthritic effect of silver nanoparticles of Moringa 
concanensis Nimmo 
3.3.1 Effect of silver nanoparticles on body weight of FCA 
induced arthritic rats 
The silver nanoparticles treated group of rats (Group IV) 
showed a similar weight gain compared with control rats 
(Group I) but this also showed a significant (p<0.05) 
increase in the body weight (Table 2) compared with FCA 
treated rats (Group II). The reference diclofenac treated rats 
(Group V) also showed a similar weight gain compared with 
control rats (Group I). This group also showed a significant 
(p<0.05) increase in the body weight compared to the FCA 
treated rats (Group II). 
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Table 2: Effect of AgNPs on body weight of FCA induced arthritic rats 
Experimental groups Initial body weight (g) Final body weight (g) 
Group I (Control) 200 ± 1.05 220 ± 1.10 
Group II (FCA) 180 ± 1.10 185 ± 1.30 
Group IV (FCA + AgNPs) 210 ± 1.10 217 ± 1.40 
Group IV     (FCA + Diclofenac) 210 ± 1.10 218 ± 1.20 
Values are expressed as mean ± S.D for six animals in each group (p<0.05). 
 
3.3.2 Effect of silver nanoparticles on changes in paw 
volume of FCA induced arthritic rats 
The arthritis was induced by the injection of complete 
freund’s adjuvant (FCA) in experimental rats for testing the 
antiarthritic activity of silver nanoparticles of Moringa 
concanensis Nimmo. The intra peritoneal administration of 
FCA in the rats (Group II), the results showed the progressive 
increase in the paw volume compared with control rats 
(Group I). The difference in the volume of injected 
(ipsilateral) and non injected (contralateral) paw between 
FCA and drug treated rats was statistically significant 
(p<0.05) in a dose dependent manner (table 3). The paw 
swelling is the index of measuring the antiarthritic activity of 
various drugs and employed here to determine the activity of 
silver nanoparticles of M.concanensis Nimmo leaves. The 
silver nanoparticles administered groups showed a marked 
reduction in paw volume when compared with the control 
group. 
 
Table 3: Effect of silver nanoparticles on changes in paw volume (P.V) 
Experimental groups Initial paw volume (ml) Final paw volume (ml) 
Group I (Control) 0.85 ± 0.10 0.86 ± 0.08 
Group II (FCA) 0.88 ± 0.06 2.95 ± 0.50 
Group III   (FCA + AgNPs) 0.86 ± 0.07 1.15 ± 0.10 
Group IV (FCA + Diclofenac) 0.85 ± 1.10 1.20 ± 0.20 
Values are expressed as mean ± S.D for six animals in each group (p<0.05). 
 
3.3.3 Effect of silver nanoparticles on changes in 
hematological parameters of FCA induced arthritic rats 
The silver nanoparticles of Moringa concanensis Nimmo 
leaves treated group showed remarkable activity in 
restoration of blood components in arthritis induced rats. 
The silver nanoparticles of Moringa concanensis Nimmo 
leaves treated rats (Group III) significantly (p<0.05)  
increased the hemoglobin, packed cell volume (PCV), red 
blood cells and platelets in the experimental rats than silver 
nanoparticles and standard drug diclofenac (Group IV and 
Group V) compared to the control (Group I). The results 
showed in (Table 4).  
 
Table 4: Effect of silver nanoparticles on changes in hematological parameters of FCA induced arthritis rats 
Experimental 
groups 
Hb (g%) PCV (%) WBC (103/µl) 
RBC 
(1012/µl) 
Platelets 
(109/µl) 
ESR 
(mm/hr) 
Group I   (Control) 14.5 ± 0.40 44 ± 0.60 6.60 ± 0.50 6.50 ± 0.40 7.50 ± 0.50 10 ± 0.27 
Group II  (FCA) 12.0 ± 0.20 36 ± 0.20 11.50 ± 1.45 5.20 ± 0.60 6.30 ± 0.50 22 ± 1.50 
Group III FCA + 
AgNPs) 
12.6 ± 0.65 42 ± 0.60 6.30 ± 0.50 6.20 ± 0.70 7.30 ± 0.50 12 ± 0.50 
Group V (FCA + 
Diclofenac) 
12.2 ± 0.20 41 ± 0.40 6.10 ± 0.70 6.30 ± 0.70 7.30 ± 0.30 13 ± 0.40 
Values are expressed as mean ± S.D for six animals in each group (p<0.05). 
 
3.3.4 Effect of silver nanoparticles on changes in serum 
liver marker enzymes of FCA induced arthritic rats 
In the present study, the challenge with FCA (0.1 ml) 
significantly (p<0.05) elevated the serum aspartate 
transaminase (AST), alanine transaminase (ALT) and 
alkaline phosphatase (ALP) level. Assessment of the serum 
levels of aspartate transaminase (AST), alanine transaminase 
(ALT) and alkaline phosphatase (ALP) provides an excellent 
and simple tool to measure the antiarthritic activity of the 
drug. The FCA induced rats showed a random increase in the 
liver function marker enzymes and this could lead to the 
fatality. The silver nanoparticles treated rats showed a 
notable decrease in the liver marker enzymes (table 5). 
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Table 5: Effect of silver nanoparticles on changes in serum liver marker enzymes 
Experimental 
groups 
AST (µl) ALT (µl) ALP (µl) ACP (µl) LDH (µl) GGT (µl) 
Group I     
(Control) 
85.23 ±1.30 65.94±0.95 115.39±1.34 4.9±0.56 324.72±1.78 19.34±1.32 
Group II    (FCA) 103.01±1.23 85.00±1.01 138.65±1.55 5.3±0.60  432.45±2.10 31.36±1.26 
Group III (FCA + 
AgNPs) 
87.13±1.35 67.43±0.93 116.02±1.31 5.0±0.61 358.12±1.46 22.98±1.10 
Group V (FCA + 
Diclofenac) 
87.26±1.29 69.01±0.87 116.52±1.22 5.1±0.57 363.00±1.48 22.26±1.37 
Values are expressed as mean ± S.D for six animals in each group (p<0.05) 
3.3.5 Effect of AgNPs on changes in serum glucose of FCA 
induced arthritic rats 
The serum glucose level of silver nanoparticles treated 
experimental rats (Group IV) showed a significant (p<0.05) 
decrease when compared to the FCA treated experimental 
rats (Group II). The silver nanoparticles administered rats 
showed a significantly (p<0.05) slight increase when 
compared to control rats (Group I) and the EEMC treated 
(Group III) rats.  
Table 6: Effect of AgNPs on changes in serum glucose of 
FCA induced arthritic rats 
Experimental Groups Glucose (mg/dl) 
Group I      (Control) 106.25 ± 0.73 
Group II     (FCA) 140.22 ± 0.67 
Group III    Group II     (FCA + AgNPs) 108.12 ± 0.63 
Group IV     (FCA + Diclofenac) 109.28 ± 0.54 
Values are expressed as mean ± S.D for six animals in each 
group (p<0.05) 
The silver nanoparticles treated rats also showed a 
significant (p<0.05) decrease in the serum glucose level of 
experimental rats when compared to standard drug 
diclofenac treated (Group V) experimental rats (Table 6). 
3.3.6 Effect of silver nanoparticles on changes in serum 
cholesterol and triglycerides of FCA induced arthritic 
rats 
The serum cholesterol level was rapidly increased after the 
induction of arthritis by using complete freund’s adjuvent 
(Group II). The silver nanopaticles showed a significant 
(p<0.05) decrease in the serum cholesterol level of 
experimental rats (Group III) when compared to FCA treated 
rats (Group II). The serum triglycerides level was 
dramatically increased after the induction of arthritis by 
using complete freund’s adjuvant (Group II) (table 7). The 
silver nanoparticles showed a significant (p<0.05) decrease 
in the serum triglycerides level of experimental rats (Group 
III) when compared to the FCA treated rats (Group II).  
 
Table 7: Effect of silver nanoparticles on changes in serum cholesterol and triglycerides 
Experimental groups Total cholesterol (mg/dl) Total triglycerides (mg/dl) 
Group I (Control) 73.45 ± 1.23 63.20 ± 0.55 
Group II (FCA) 96.32 ± 0.21 88.45 ± 0.95 
Group III (  Group III FCA + AgNPs) 76.48 ± 0.92 67.34 ± 0.40 
Group V     Group IV (FCA + Diclofenac) 77.37 ± 0.27 68.38 ± 0.28 
Values are expressed as mean ± S.D for six animals in each group (p<0.05) 
 
3.3.7 Effect of silver nanoparticles on changes in serum 
of renal function markers of FCA induced arthritic rats 
The estimation of renal function markers in the serum is an 
important parameter for assaying the antiarthritic activity of 
plant extracts and drugs. The FCA treated rats was showed a 
dramatically increased level in the renal function markers 
such as, urea, creatinine, uric acid and albumin. The 
treatment with silver nanoparticles of M.concanensis leaves 
showed a significant (p<0.05) restoration of renal function 
markers (table 8). 
 
Table 8: Effect of silver nanoparticles on changes in serum of renal function markers of FCA induced arthritic rats 
Experimental 
groups 
Urea (mg/dl) 
Creatinine 
(mg/dl) 
Uric acid 
(mg/dl) 
Protein g/dl) 
Albumin 
(g/dl) 
CRP (µg/ml) 
Group I (Control) 14.07 ± 0.76 0.76 ± 0.05 2.05 ± 0.15 6.35 ± 0.45 3.71 ± 0.25 4.64 ± 0.59 
Group II (FCA) 26.2 ± 0.95 2.02 ± 1.05 3.21 ± 0.23 4.25 ±0. 83 2.45 ± 0.22 20.53±1.67 
Group III (FCA + 
AgNPs) 
15.47 ± 0.65 0.97 ± 0.06 2.22 ± 0.10 6.30 ± 0.47 3.23 ± 0.28 8.28 ± 0.27 
Group V (FCA + 
Diclofenac) 
16.83 ± 0.66 1.00 ± 0.09 2.53 ± 0.14 6.25 ± 0.50 3.45 ± 0.31 9.77 ± 0.42 
Values are expressed as mean ± S.D for six animals in each group (p<0.05) 
 
3.4 Histopathological evaluation of hind limb 
Histopathological assessment of joints from treated and 
control rats revealed remarkable signs of cellular infiltration, 
synovial hyperplasia, pannus formation, partial cartilage and 
bone destruction in the untreated FCA rats.  
The normal connective tissue structure with the absence of 
necrosis in the tibiotarsal joint was observed in the control 
group. The silver nanoparticles treated rats produced knee 
joint protection compared to arthritic rats by reducing the 
inflammation and necrosis. However, the synthesized silver 
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nanoparticles treated rats had significantly (p<0.05) 
decreased the levels of cellular infiltration, hyperplasia and 
bone destruction and this improved histopathology 
compared to the FCA treated rats (Figure 1). Rats treated 
silver nanoparticles showed mild necrosis with edema but 
granuloma was absent in tibiotarsal joint. 
 
 
Group I (Control)     Group II (FCA treated) 
 
Group III (AgNPs treated)                          Group V (Diclofenac treated) 
Figure 1: Histopathological analysis of hind limb 
3.5 Histopathological analysis of liver  
Histological changes in the liver there was a no toxic effect 
on the liver of experimental rats with FCA treated was 
detected after the treatment with silver nanoparticles. The 
AgNPs treatment decreased the alteration of hepatic 
parenchyma and general inflammatory infiltration of hepatic 
stoma in comparison with the control group. Slight observed 
dystrophy in the liver of the silver nanoparticles treated 
groups means the alterations some of which maybe are 
reversible while a hard dystrophy can be irreversible, that 
means progressing to necrosis.  
 
             
Group I (Control)     Group II (FCA treated) 
             
Group III (FCA + AgNPs treated)     Group V (FCA + Diclofenac treated) 
Figure 2: Histopathological analysis of liver 
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4. DISCUSSION 
Rheumatoid arthritis is a long term inflammatory 
autoimmune disease that causes chronic joint inflammation 
with the symptoms of pain, swelling, and stiffness in the 
hands, feet, knees, and wrists. Rheumatoid arthritis is 
generally characterized by chronic synovial inflammation of 
the joints, resulting in the degradation and destruction of 
cartilages and bones, and has poor outcomes with limited 
treatment options. Despite the lack of robust epidemiological 
studies in some regions and the difference in Rheumatoid 
arthritis prevalence between ethnicities, the prevalence of 
Rheumatoid arthritis is the highest among the inflammatory 
autoimmune diseases, ranging from 0.5 to 1% of the 
population worldwide13-16. Freund's complete adjuvant 
induced arthritis in rat model is the best and most widely 
used experimental model for arthritis. It is a T cell and 
neutrophil dependent and complement independent helper 
inflammatory cytokines are associated CFA induced 
arthritis17. 
Silver was the only material that the plasmon resonance can 
be turned to any wavelength in the visible spectrum8. Studies 
carried out in the last few decades shows that silver 
nanoparticles exhibit a rare combination of valuable 
properties like catalytic activity, high electrical double layer 
capacitance etc. Nanosilver has also been used extensively as 
antibacterial agent in the health industry, food storage, 
textile and a number of environmental applications18-20. The 
rheumatoid arthritis is associated with the weight loss and 
this loss of body weight leads to the lean body, known as 
rheumatoid cachexia. Rheumatoid cachexia is thought to be 
the end result of cytokine driven hyper metabolism and was 
a key comorbidity in rheumatoid arthritis21,22.  
Reduction in bone configuration and increased bone 
resorption are the causes of bone loss in FCA induced 
arthritic rats. This has been reported that a moderate rise in 
the WBC count occurs in arthritic conditions due to an IL-1β 
mediated rise in the respective colony stimulating factors 
and reduction in hemoglobin count in arthritis results from 
reduced erythropoietin levels, a decreased response of the 
bone marrow erythropoietin and premature destruction of 
red blood cells23. The experimental rats treated with FCA 
exhibited the rapid elevation in white blood cells (WBC) and 
erythrocytes sedimentation rate (ESR) and exhibited the 
decreases in red blood cells (RBC), platelets and hemoglobin. 
The AgNPs showed the noticeable elevation in red blood 
cells, hemoglobin and platelets and also prevent the rapid 
elevation of white blood cells and erythrocyte sedimentation 
rate. In these results a slight differences was noted, that the 
AgNPs possess the better activity. 
The rats treated with the FCA showed the rapid increases in 
the liver marker enzymes such as aspartate transaminase 
(AST), alanine transaminase (ALT), alkaline phosphatase 
(ALP), lactate dehydrogenase (LDH) and gamma glutamyl 
transferase (γ-GT). The increases of these enzymes may 
possess the deformity of liver function. The AgNPs exhibited 
the marked decreases and set back to control of these 
enzymes in experimental rats. The serum glucose, 
cholesterol, triglycerides and urea level was rapidly 
increased in the rats after the FCA treatment. The AgNPs was 
exhibited the decrease of glucose, cholesterol, triglycerides, 
creatinine, uric acid and urea level in the serum of 
experimental rats. 
 Histopathological analysis of joints of FCA treated and 
control rats revealed remarkable signs of cellular infiltration, 
synovial hyperplasia, pannus formation, partial cartilage and 
bone destruction in the FCA treated rats compared to 
control. The AgNPs treated rats produced knee joint 
protection compared to arthritic rats by reducing the 
inflammation and necrosis. However, AgNPs treated rats 
were decreased the levels of cellular infiltration, hyperplasia 
and bone destruction and this improved histopathology was 
contributed by the silver nanoparticles. The rats treated 
silver nanoparticles showed mild necrosis with edema but 
granuloma was absent in tibiotarsal joint. Histological 
changes in the liver there was a no toxic effect on the liver of 
experimental rats with FCA treated was detected after the 
treatment with AgNPs. Both treatments decreased the 
alteration of hepatic parenchyma and general inflammatory 
infiltration of hepatic stoma in comparison with the control 
group. Based on the present study, this was clear that the 
new finding clearly indicates that the silver nanoparticles 
from Moringa concanensis Nimmo leaves was possessed the 
excellent antiarthritic activity.  
5. CONCLUSION  
The present study was concluded with the new findings was 
clearly indicates that the silver nanoparticles from Moringa 
concanensis Nimmo leaves was possessed the notable 
antiarthritic activity. These results may leads to the 
development of novel antiarthritic drugs from the plant 
Moringa concanensis Nimmo.  
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